Clinical trialPhase 2Completed
Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
A Multi-Center Randomized Phase II Study of Induction Chemotherapy Followed by Gemcitabine or Capecitabine Based Chemoradiotherapy for Locally Advanced Non-Metastatic Pancreatic Cancer
- Outcome
- Finished, no results posted
- Phase
- Phase 2
- Status
- Completed
- Study type
- Interventional
- Start
- July 2009
- Expected end
- June 2013
- Enrollment
- 114 participants
- Sites
- 26
- Primary outcomes
- Progression-free survival at 39 weeks (from registration) according to RECIST criteria
- Sponsor
- Other
- Results posted
- No
- Last update
- 26 October 2018
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 3
- Registry-listed results paperComparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the … DOI 10.1016/j.radonc.2016.07.002↗
- Registry-listed results paperComparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the p… DOI 10.1016/j.radonc.2015.08.026↗
- Registry-listed results paperGemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentr… DOI 10.1016/s1470-2045(13)70021-4↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.